Dermatomyositis (DM ... This disease is characterized by debilitating muscle weakness and distinctive skin rashes. Notably, about half of those affected experience falls, and one-third require ...
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...